Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

53.79
Delayed Data
As of Dec 09
 +0.32 / +0.60%
Today’s Change
28.01
Today|||52-Week Range
60.98
+29.61%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.50, with a high estimate of 65.00 and a low estimate of 54.00. The median estimate represents a +6.90% increase from the last price of 53.79.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.59
Sales
$7.1M
Reporting Date
Mar 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.45%
 
 
 
 
 
 
Growthannually -124.87%
 
 
 
 
 

Sales

Growthquarterly 6.00%
 
 
 
 
 
 
Growthannually -92.22%
 
 
 
 
 
Key to the earnings and sales forecast charts.